Cigna Group $CI Shares Bought by IFP Advisors Inc

IFP Advisors Inc grew its position in shares of Cigna Group (NYSE:CI) by 32.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 13,599 shares of the health services provider’s stock after acquiring an additional 3,359 shares during the quarter. IFP Advisors Inc’s holdings in Cigna Group were worth $3,743,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Banque Cantonale Vaudoise boosted its holdings in shares of Cigna Group by 17.6% during the fourth quarter. Banque Cantonale Vaudoise now owns 17,267 shares of the health services provider’s stock valued at $4,753,000 after acquiring an additional 2,590 shares during the period. Cullen Frost Bankers Inc. boosted its holdings in shares of Cigna Group by 3.4% during the fourth quarter. Cullen Frost Bankers Inc. now owns 3,486 shares of the health services provider’s stock valued at $959,000 after acquiring an additional 113 shares during the period. Creative Financial Designs Inc. ADV boosted its holdings in shares of Cigna Group by 147.3% during the fourth quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock valued at $37,000 after acquiring an additional 81 shares during the period. Hudson Canyon Capital Management boosted its holdings in shares of Cigna Group by 6.0% during the fourth quarter. Hudson Canyon Capital Management now owns 6,665 shares of the health services provider’s stock valued at $1,834,000 after acquiring an additional 375 shares during the period. Finally, Fideuram Intesa Sanpaolo Private Banking S.P.A. acquired a new position in shares of Cigna Group during the fourth quarter valued at $3,304,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Price Performance

Shares of NYSE CI opened at $281.84 on Friday. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $338.89. The firm’s 50-day simple moving average is $276.12 and its 200 day simple moving average is $276.03. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The stock has a market cap of $74.56 billion, a P/E ratio of 11.95, a P/E/G ratio of 0.99 and a beta of 0.30.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. During the same period in the previous year, the business earned $6.74 earnings per share. The company’s revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities analysts expect that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a $1.56 dividend. The ex-dividend date is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s payout ratio is 26.45%.

Insiders Place Their Bets

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 205,904 shares of company stock worth $60,277,068. 0.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CI. Jefferies Financial Group reduced their price target on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a report on Monday, April 20th. Cantor Fitzgerald lifted their price objective on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Leerink Partners lifted their price objective on shares of Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a research note on Friday, February 6th. Mizuho set a $330.00 price objective on shares of Cigna Group in a research note on Friday, May 1st. Finally, UBS Group restated a “buy” rating and set a $375.00 price objective on shares of Cigna Group in a research note on Monday, February 9th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cigna Group presently has an average rating of “Moderate Buy” and an average price target of $338.55.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.